Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Meta-analysis
56%
Systematic Literature Review
50%
Retrospective Cohort Study
42%
Laser Therapy
31%
Israel
29%
Psoriasis
29%
Variegate Porphyria
22%
Omalizumab
22%
Erythropoietic Protoporphyria
21%
Solar Urticaria
20%
Real-world Experience
18%
Epidemiology
18%
Hereditary Coproporphyria
17%
Patch Test
16%
Israeli
15%
Rituximab
13%
CO2 Laser
12%
Potassium Dichromate
12%
Cyclin-dependent Kinase 6 (CDK6)
12%
Leukoderma
12%
Cyclin-dependent Kinase 4 (CDK4)
12%
Vitiligo
12%
Cutaneous Porphyria
12%
Systemic Retinoids
12%
Topical Retinoids
12%
Light Therapy
12%
Hair Removal
12%
Biologic Therapy
12%
European Baseline Series
11%
95% Confidence Interval
11%
Recurrence Rate
10%
Antihistamines
10%
Severity Index
10%
Area Index
10%
Pruritus
9%
Acrylate
9%
Clinical Features
9%
Longitudinal Melanonychia
9%
Radiotherapy
8%
Adverse Effects
8%
Porphyria
8%
Retrospective Case Series
8%
Atopic Dermatitis
7%
Tertiary Care Centers
7%
Low Risk
7%
Pediatric
7%
Allergic Contact Dermatitis
7%
Quality of Life
7%
National Cohort Study
7%
Retrospective Cohort
7%
Medicine and Dentistry
Systematic Review
100%
Meta-Analysis
50%
Retrospective Cohort Study
34%
Nail
21%
Variegate porphyria
21%
Solar Urticaria
20%
Erythropoietic Protoporphyria
20%
Psoriasis
18%
Cohort Effect
18%
Quality of Life
18%
Carbon Dioxide
18%
Low Level Laser Therapy
16%
Hereditary Coproporphyria
16%
Omalizumab
15%
Phototherapy
13%
Diseases
13%
Acneiform Eruption
12%
Hair Removal
12%
Dichromate Potassium
12%
Porphyria Cutanea Tarda
12%
Contact Dermatitis
12%
Cyclin-Dependent Kinase 6
12%
Leukoderma
12%
Vitiligo
12%
Cyclin-Dependent Kinase 4
12%
Nail Disease
12%
Genetics
12%
Personal Experience
12%
Laser Therapy
12%
Atopic Dermatitis
10%
Histamine Antagonist
10%
2 Hydroxyethyl Methacrylate
9%
Exanthem
9%
Recurrence Risk
9%
Prevalence
9%
Allergen
8%
Clinical Feature
8%
Photochemotherapy
8%
Skin Allergy
8%
Radiation Therapy
8%
Porphyria
8%
Pemphigus
8%
Patch Test
8%
Cosmetics
8%
Adolescence
7%
Adverse Effect
7%
Cohort Studies
7%
Immunosuppressive Treatment
7%
Adverse Event
7%
Acrylic Acid
7%